Fideuram Asset Management Ireland dac Makes New Investment in UnitedHealth Group Incorporated $UNH

Key Points

• Fideuram Asset Management Ireland dac opened a new position in UnitedHealth Group during the fourth quarter, buying 9,872 shares valued at about $3.26 million.
• Institutional ownership remains high, with hedge funds and asset managers holding 87.86% of the company, while several large investors significantly increased their stakes in recent quarters.
• Analyst sentiment is broadly bullish: multiple firms raised price targets, and the stock now carries a consensus Moderate Buy rating with an average target of about $397.63.

Fideuram Asset Management Ireland dac bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 9,872 shares of the healthcare conglomerate's stock, valued at approximately $3,259,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Capital Research Global Investors increased its position in UnitedHealth Group by 126.9% during the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate's stock worth $4,503,419,000 after purchasing an additional 7,293,009 shares during the period. Capital World Investors increased its position in UnitedHealth Group by 18.8% during the 3rd quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate's stock worth $7,516,107,000 after purchasing an additional 3,439,182 shares during the period. Capital International Investors increased its position in UnitedHealth Group by 11.1% during the 3rd quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate's stock worth $6,042,710,000 after purchasing an additional 1,747,337 shares during the period. Lone Pine Capital LLC acquired a new position in UnitedHealth Group during the 2nd quarter worth approximately $528,273,000. Finally, Bessemer Group Inc. grew its holdings in shares of UnitedHealth Group by 152.3% in the 3rd quarter. Bessemer Group Inc. now owns 1,823,871 shares of the healthcare conglomerate's stock worth $629,783,000 after acquiring an additional 1,100,850 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer owned 17,805 shares of the company's stock, valued at $6,320,775. This represents a 4.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 0.28% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts have commented on the company. Argus upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $400.00 target price on the stock in a research report on Wednesday, April 22nd. HSBC upgraded UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $300.00 target price on the stock in a research report on Tuesday, April 7th. Leerink Partners boosted their target price on UnitedHealth Group from $345.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 22nd. Royal Bank Of Canada boosted their target price on UnitedHealth Group from $361.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 22nd. Finally, Barclays boosted their target price on UnitedHealth Group from $373.00 to $429.00 and gave the stock an "overweight" rating in a research report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $397.63.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Bernstein raised its price target on UnitedHealth Group (UNH) to $492 from $444 and reiterated an Outperform rating, citing an EPS recovery outlook and implying meaningful upside. Article Title
• Positive Sentiment: Bernstein also maintained its bullish stance after UnitedHealth’s new, more transparent PBM model, suggesting the move could improve clarity, reliability, and cost competitiveness for the company’s Optum Rx business. Article Title
• Positive Sentiment: Coverage from Zacks and other market watchers says UNH is one of the most-tracked stocks right now, which can keep attention on the name and support sentiment if investors expect more upside. Article Title
• Neutral Sentiment: Articles comparing UnitedHealth with Molina highlight that Molina’s Medicaid exposure and share gains currently look more attractive to some analysts, but these pieces are more relative-value commentary than a direct negative catalyst for UNH. Article Title
• Neutral Sentiment: Seeking Alpha commentary on a possible dividend hike adds a shareholder-return angle, but it does not appear to be based on a confirmed corporate action yet. Article Title
• Neutral Sentiment: Recent “trending stock” and “bull case” articles suggest investors are reassessing UNH’s outlook, but they are largely opinion pieces rather than new fundamental developments. Article Title

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $382.28 on Friday. The business's fifty day moving average price is $334.93 and its two-hundred day moving average price is $321.14. The stock has a market cap of $347.16 billion, a PE ratio of 28.87, a price-to-earnings-growth ratio of 1.66 and a beta of 0.64. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $404.15.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating analysts' consensus estimates of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to analysts' expectations of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.UnitedHealth Group's quarterly revenue was up 2.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 18.29 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.